异种移植
人脑
鼻腔给药
医学
小胶质细胞
中枢神经系统
脑组织
创伤性脑损伤
神经科学
神经组织
免疫学
病理
免疫系统
大鼠模型
血管生成
药理学
内生
再生(生物学)
炎症
运动皮层
全身给药
脑损伤
移植
神经系统
作者
Nina Colitti,Edwige Rice,Franck Desmoulin,Maylis Combeau,Mélissa Parny,Lorenne Robert,Étienne Buscail,Barbara Bournet,Nathalie Vergnolle,Isabelle Raymond‐Letron,Isabelle Loubinoux,Carla Cirillo
标识
DOI:10.1002/advs.202503362
摘要
Acute brain injuries are characterized by extensive tissue damage, resulting in functional deficits in patients. The capacity of nerve tissue to self-regenerate is insufficient, thus therapies based on exogenous cells are urgently needed. Human enteric glia (EG) have interesting intrinsic properties that make them a valuable candidate for regenerative medicine. Malonate-induced acute brain injury is performed in the motor cortex of female rats, causing extensive tissue damage and long-lasting sensorimotor deficits. Human EG are isolated, expanded and administered intranasally in awake immunocompetent rats. To determine the long-term safety and efficacy of human EG treatment, longitudinal evaluation of sensorimotor function, post-mortem tissue analysis and the fate of human EG are assessed thirty-six-weeks post-injury. Transplanted human EG are well tolerated in immunocompetent rats. Thirty-six-weeks post-injury, intranasally delivered human EG are detected in the rat brain, mainly in the injured motor cortex. They engraft and integrate with the host tissue, and enhance endogenous angiogenesis and neurogenesis. Notably, mature neurons derived from human EG are found and appear enveloped by oligodendrocytes, form synaptic connections with the host tissue, and are differentiated. This is the first study demonstrating the feasibility, safety and efficacy of intranasal administration of human EG for treatment of brain injury.
科研通智能强力驱动
Strongly Powered by AbleSci AI